Geode Capital Management Portfolio holdings
Geode Capital Management, founded in 2001 and based in Boston, Massachusetts, is a prominent institutional asset management firm known for its expertise in low-cost, systematic index investing. Originally established to manage internal index funds for Fidelity Investments, Geode became an independent entity while retaining a close relationship with Fidelity, focusing on passive investment strategies that track major market indices. The firm oversees hundreds of billions in assets, offering a range of mutual funds and separately managed accounts primarily for institutional clients, such as pension funds and endowments, with an emphasis on minimizing costs and maximizing efficiency. Geode’s disciplined, quantitative approach and avoidance of active management have made it a key player in the rise of index-based investing.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Microsoft
MSFT
|
+$1.18B |
| 2 |
Apple
AAPL
|
+$1.11B |
| 3 |
Broadcom
AVGO
|
+$562M |
| 4 |
Amazon
AMZN
|
+$553M |
| 5 |
Palo Alto Networks
PANW
|
+$485M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Procter & Gamble
PG
|
+$246M |
| 2 |
O'Reilly Automotive
ORLY
|
+$149M |
| 3 |
Cadence Design Systems
CDNS
|
+$149M |
| 4 |
Synopsys
SNPS
|
+$134M |
| 5 |
Chipotle Mexican Grill
CMG
|
+$125M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.24% |
| 2 | Healthcare | 13.33% |
| 3 | Financials | 12.09% |
| 4 | Consumer Discretionary | 10.85% |
| 5 | Industrials | 9.11% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
SEMR
2576
DELISTED
Semrush
SEMR
| $6.18M | ﹤0.01% |
646,264
+310,322
| +92% | +$2.74M |
|
2577
Utah Medical Products
UTMD
$232M
| $6.18M | ﹤0.01% |
66,328
-5,083
| -7% | -$479K |
|
2578
Aura Biosciences
AURA
$728M
| $6.17M | ﹤0.01% |
499,596
+41,688
| +9% | +$446K |
|
|
DSKE
2579
DELISTED
Daseke, Inc. Common Stock
DSKE
| $6.17M | ﹤0.01% |
864,737
-100,362
| -10% | -$705K |
|
2580
Atea Pharmaceuticals
AVIR
$369M
| $6.15M | ﹤0.01% |
1,645,038
+154,974
| +10% | +$580K |
|
|
HLVX
2581
DELISTED
HilleVax
HLVX
| $6.14M | ﹤0.01% |
357,322
+70,046
| +24% | +$1.09M |
|
2582
Coherus Oncology
CHRS
$222M
| $6.07M | ﹤0.01% |
1,420,608
+112,238
| +9% | +$662K |
|
2583
Entrada Therapeutics
TRDA
$282M
| $6.07M | ﹤0.01% |
400,631
+216,841
| +118% | +$2.99M |
|
|
LUNA
2584
DELISTED
Luna Innovations Incorporated
LUNA
| $6.05M | ﹤0.01% |
662,945
+353,576
| +114% | +$2.8M |
|
2585
Amalgamated Financial
AMAL
$1.48B
| $6.04M | ﹤0.01% |
375,298
+23,399
| +7% | +$376K |
|
2586
Arrow Financial
AROW
$667M
| $6.02M | ﹤0.01% |
307,816
+9,256
| +3% | +$189K |
|
|
CANO
2587
DELISTED
Cano Health, Inc.
CANO
| $6M | ﹤0.01% |
43,190
+11,391
| +36% | +$1.46M |
|
|
ARIS
2588
DELISTED
Aris Water Solutions
ARIS
| $5.99M | ﹤0.01% |
580,534
+128,352
| +28% | +$1.11M |
|
2589
Blink Charging
BLNK
$78M
| $5.99M | ﹤0.01% |
999,784
+81,949
| +9% | +$568K |
|
|
MOFG
2590
DELISTED
MidWestOne Financial Group
MOFG
| $5.99M | ﹤0.01% |
280,118
+13,282
| +5% | +$276K |
|
|
CNSL
2591
DELISTED
Consolidated Communications Holdings, Inc.
CNSL
| $5.99M | ﹤0.01% |
1,562,742
+73,244
| +5% | +$264K |
|
2592
Kodak
KODK
$828M
| $5.98M | ﹤0.01% |
1,294,053
+77,170
| +6% | +$325K |
|
|
ASRT
2593
DELISTED
Assertio
ASRT
| $5.98M | ﹤0.01% |
73,503
+42,963
| +141% | +$3.99M |
|
2594
Arbutus Biopharma
ABUS
$861M
| $5.98M | ﹤0.01% |
2,598,126
+310,213
| +14% | +$807K |
|
|
ONTF
2595
DELISTED
ON24
ONTF
| $5.97M | ﹤0.01% |
735,079
-78,769
| -10% | -$654K |
|
2596
Peoples Financial Services
PFIS
$704M
| $5.97M | ﹤0.01% |
136,300
-2,671
| -2% | -$109K |
|
2597
Genesco
GCO
$435M
| $5.95M | ﹤0.01% |
237,696
-748
| -0.3% | -$21.7K |
|
|
TPC
2598
Tutor Perini Cor
TPC
$4.51B
| $5.94M | ﹤0.01% |
831,063
+19,470
| +2% | +$116K |
|
|
AMNB
2599
DELISTED
American National Bankshares Inc
AMNB
| $5.92M | ﹤0.01% |
204,325
+6,141
| +3% | +$177K |
|
2600
LanzaTech
LNZA
$64.3M
| $5.91M | ﹤0.01% |
+8,659
| New | +$3.42M |
|
Similar funds
Geode Capital Management's Q2 2023 Portfolio in Review
As of Q2 2023, Geode Capital Management held 4,889 positions worth $851B, up 11% from $770B the previous quarter. Its ten largest holdings account for 26% of the portfolio.
Trading was light in Q2 2023: portfolio turnover was 4.4%. Geode Capital Management opened 83 new positions and exited 132, leaving the 4,889-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 28% of assets, up from 26% a quarter earlier, followed by Healthcare and Financials.
- Geode Capital Management's largest Q2 2023 buy was Coupang: 4,567,454 shares worth $79.5M.
- Geode Capital Management added most to Microsoft in Q2 2023, an estimated $1.18B increase.
- Geode Capital Management's biggest Q2 2023 reduction was Procter & Gamble, cutting an estimated $246M.
- Geode Capital Management fully exited Evoqua Water Technologies Corp. Common Stock in Q2 2023, selling an estimated $111M.
- Geode Capital Management's ten largest holdings make up 26% of its $851B portfolio in Q2 2023.
- Geode Capital Management opened 83 new positions and closed 132 in Q2 2023.
- Geode Capital Management's portfolio value rose 11% quarter-over-quarter to $851B.
Based on Geode Capital Management's 13F filing for Q2 2023, filed 11 Aug 2023.